The HIV+Hepatitis Policy Institute, a non-profit organization, is very grateful for support from individuals, foundations, and corporations that invest in our mission to promote quality and affordable healthcare for people living with or at risk of HIV, hepatitis, and other serious and chronic health conditions. The HIV and Hepatitis Policy Institute is a 501(c)(3) tax-exempt organization. Donations to HIV+Hep are tax-deductible to the full extent allowed by law.
If you are interested in making a donation, please contact: Carl Schmid, Executive Director, at cschmid@hivhep.org.
1602B Belmont Street NW | Washington DC 20009
Facebook posts by @HIV+Hep
Stakeholders Warn Hep C Subscription Model May Not Work For GLP-1s: insidehealthpolicy.com/inside-drug-pricing-daily-news/stakeholders-warn-hep-c-subscription-model-...
PBMs Urged To Ensure New TrumpRx Prices Count Toward OOP Insurance Obligations: insidehealthpolicy.com/inside-drug-pricing-daily-news/pbms-urged-ensure-new-trumprx-prices-count-...
The HIV and Hepatitis Policy Institute and Arthritis Foundation sent a letter urging Pharmaceutical Care Management Association (PCMA) members to clearly disclose whether purchases through #TrumpRx will count toward patients’ deductibles and out-of-pocket maximums. A lower price today shouldn’t leave patients paying more over the course of the year: bit.ly/4zqaltX
As @CMSgov codifies Medicare Rx Price negotiation rules, it must ensure lower prices translate into real access & affordability for patients. Read our comment urging meaningful public engagement, greater transparency, & enforceable access protections for selected Rxs: bit.ly/4hXzLJp
Medicaid’s new work requirement could put HIV care at risk:
Medicaid’s new work requirement could put HIV care at risk
positivelyaware.com
More than a decade ago, when the Affordable Care Act (ACA) gave states the option of expanding Medicaid to cover more low-income people, many people living with HIV in the states that took the option ...